Home/Attyloid/Dr. Oliver Bannach
DO

Dr. Oliver Bannach

CEO, Co-founder

Attyloid

Attyloid Pipeline

DrugIndicationPhase
sFIDA Platform for CNS BiomarkersAlzheimer's Disease, Parkinson's Disease (Diagnostics & Monitoring)Clinical Validation
sFIDA for Drug Development ServicesTarget engagement & efficacy testing for protein aggregation therapiesResearch Services
sFIDA for Subvisible Particle AnalysisBiopharmaceutical R&D & Quality ControlResearch Services
sFIDA for Viral Particle AnalysisVaccine production & viral therapeutic developmentResearch Services